Law360 (August 18, 2021, 4:28 PM EDT) — The Patent Trial and Appeal Board … versions of Neulasta on the market before Amgen’s patent expires. … are different in their legal bases, and given the breadth of petitioner’s stipulation …
Law360 (August 18, 2021, 4:28 PM EDT) — The Patent Trial and Appeal Board … versions of Neulasta on the market before Amgen’s patent expires. … are different in their legal bases, and given the breadth of petitioner’s stipulation …